With a strong background in technology and healthcare investments, the fund manager has successfully executed over 15 deals, demonstrating a keen ability to identify high-potential opportunities. Active in North America and Europe, their strategic style leans towards a data-driven approach, allowing for informed decision-making throughout various investment stages. Notable exits in the biotech sector highlight their expertise in navigating complex market landscapes. Their focus on operator-first strategies ensures alignment with portfolio companies, fostering sustainable growth and innovation.